Wynzora
Active Ingredient(s): Betamethasone Dipropionate + CalcipotrieneFDA Approved: * July 20, 2020
Pharm Company: * MC2
Category: Skin Care
* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".
Wynzora Overview
Calcipotriol/betamethasone dipropionate, sold under the brand name Taclonex among others, is a fixed-dose combination medication of the synthetic vitamin D3 analog calcipotriol (also known as calcipotriene) and the synthetic corticosteroid betamethasone dipropionate for the treatment of plaque psoriasis.[3][4][5] It is used in the form of ointment, topical suspension, gel, aerosol, and foam.[2][3][4 ...
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Betamethasone/calcipotriol
Recent Wynzora Forums:
Be the first to start a discussion about this drug.Possible Dosages for this and Related Drugs:
Betamethasone Dipropionate + Calcipotriene
- Aerosol, Foam: 0.064% + 0.005%
- Cream: 0.064% + 0.005%
- Foam: 0.005% + 0.064%
- Ointment: 0.064% + 0.005%
- Suspension: 0.064% + 0.005%
Drugs with one or more similar ingredients: (9 results)
- BETAMETHASONE DIPROPIONATE + CALCIPOTRIENE HYDRATE
- CALCIPOTRIENE + BETAMETHASONE DIPROPIONATE
- ENSTILAR Calcipotriene + Betamethasone Dipropionate
- TACLONEX Betamethasone Dipropionate + Calcipotriene Hydrate
- TACLONEX SCALP Calcipotriene + Betamethasone Dipropionate
- CALCIPOTRIENE
- DOVONEX Calcipotriene
- SERNIVO Betamethasone Dipropionate
- SORILUX Calcipotriene